Shares of Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report) were down 0.5% during mid-day trading on Wednesday . The stock traded as low as $0.94 and last traded at $0.94. Approximately 2,402 shares were traded during mid-day trading, a decline of 11% from the average daily volume of 2,709 shares. The stock had previously closed at $0.94.
Fresh Tracks Therapeutics Trading Down 0.5 %
The firm has a market capitalization of $5.58 million, a PE ratio of -0.66 and a beta of 0.54. The firm has a 50 day simple moving average of $0.93 and a 200 day simple moving average of $0.79.
Fresh Tracks Therapeutics Company Profile
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
See Also
- Five stocks we like better than Fresh Tracks Therapeutics
- 3 Dividend Kings To Consider
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What Are Growth Stocks and Investing in Them
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
